@article{fdi:010049425, title = {{WHO} clinical criteria-based initiation of antiretroviral therapy : lessons from rural district hospitals in {C}ameroon with regard to 2009 revised {WHO} recommendations}, author = {{K}ouanfack, {C}. and {L}aborde-{B}alen, {G}. and {A}ghokeng {F}obang, {A}velin and {B}ourgeois, {A}. and {D}ontsop, {M}. and {M}ben, {J}. {M}. and {K}aze, {S}. and {M}poudi-{N}gole, {E}. and {K}oulla-{S}hiro, {S}. and {D}elaporte, {E}ric and {L}aurent, {C}hristian}, editor = {}, language = {{ENG}}, abstract = {{P}>{O}bjective {T}o assess the proportion of patients infected with {HIV} with a {CD}4 count above 350 cells/mm3 among those classified at {WHO} clinical stage 3 or 4 who initiated antiretroviral therapy in rural district hospitals in {C}ameroon to assess the 2009 revised {WHO} recommendations. {M}ethods {C}ross-sectional study in nine rural district hospitals where the treatment initiation is based on the {WHO} clinical criteria. {T}he proportion of patients who were classified at stage 3 or 4 and who had a {CD}4 count > 350 cells/mm3 was assessed. {R}esults {O}f 458 patients included in 2006-2008 (women 70.5%; median age 37.0 years), 337 (73.6%) were classified at {WHO} clinical stage 3 and 121 (26.4%) at stage 4. {O}verall, 108 patients (23.6%) had a {CD}4 count > 350 cells/mm3. {O}f them, 94 patients (20.5%) were classified at {WHO} clinical stage 3, and 14 (3.1%) were classified at {WHO} clinical stage 4. {C}onclusion {T}he {WHO} clinical stages 3 and 4 were poorly correlated with the 'gold standard' of {CD}4 cell count. {T}his study highlights the need to promote {CD}4 testing for assessing the patient eligibility.}, keywords = {{A}frica ; antiretroviral therapy ; {HIV} ; {W}orld {H}ealth {O}rganization criteria}, booktitle = {}, journal = {{T}ropical {M}edicine and {I}nternational {H}ealth}, volume = {15}, numero = {5}, pages = {580--583}, ISSN = {1360-2276}, year = {2010}, DOI = {10.1111/j.1365-3156.2010.02495.x}, URL = {https://www.documentation.ird.fr/hor/fdi:010049425}, }